Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Peripheral T-cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02825147
What this trial is testing

Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma

Who this might be right for
Nasal Type Extranodal NK/T-Cell Lymphoma
Ruijin Hospital 40
Early research (Phase 1)Study completedNCT02809573
What this trial is testing

Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients

Who this might be right for
Peripheral T-cell Lymphoma
Chipscreen Biosciences, Ltd. 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07032532
What this trial is testing

Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)

Who this might be right for
Peripheral T Cell Lymphoma
Sun Yat-sen University 35
Testing effectiveness (Phase 2)Study completedNCT01198665
What this trial is testing

RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas

Who this might be right for
Peripheral T Cell Lymphoma UnspecifiedAnaplastic Large Cell Lymphoma, ALK-negativeAngioimmunoblastic T Cell Lymphoma+1 more
Samsung Medical Center 46
Testing effectiveness (Phase 2)Looking for participantsNCT06583083
What this trial is testing

Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Sun Yat-sen University 84
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07706959
What this trial is testing

New Genotype-guided Treatment in Newly Diagnosed PTCL

Who this might be right for
Peripheral T-cell Lymphoma (PTCL)
Ruijin Hospital 108
Large-scale testing (Phase 3)Looking for participantsNCT05931263
What this trial is testing

Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 104
Large-scale testing (Phase 3)Looking for participantsNCT06072131
What this trial is testing

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Acrotech Biopharma Inc. 504
Testing effectiveness (Phase 2)Looking for participantsNCT05477264
What this trial is testing

Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type

Who this might be right for
Lymphoma
Won Seog Kim 38
Testing effectiveness (Phase 2)Ended earlyNCT00441025
What this trial is testing

The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL

Who this might be right for
Peripheral T-Cell Lymphoma
Mahidol University 4
Testing effectiveness (Phase 2)Ended earlyNCT01746173
What this trial is testing

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

Who this might be right for
T-cell Non-Hodgkin Lymphoma
Dana-Farber Cancer Institute 5
Large-scale testing (Phase 3)UnknownNCT03952572
What this trial is testing

Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Peking University 244
Testing effectiveness (Phase 2)Study completedNCT00211185
What this trial is testing

ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, Peripheral
Eisai Inc. 49
Not applicableWithdrawnNCT00513188
What this trial is testing

Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
University of Miami
Not applicableUnknownNCT03884205
What this trial is testing

GDPE/CEOPE Compared With CEOPE for Newly Diagnosed Patients With PTCL

Who this might be right for
PTCLGemcitabine
Shandong Provincial Hospital 120
Large-scale testing (Phase 3)Looking for participantsNCT04365036
What this trial is testing

A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)

Who this might be right for
NK/T Cell Lymphoma Nos
Sun Yat-sen University 207
Large-scale testing (Phase 3)UnknownNCT03623087
What this trial is testing

SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

Who this might be right for
Non-Hodgkin's Lymphoma, RelapsedNon-Hodgkin T-cell LymphomaNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
The University of Hong Kong 68
Large-scale testing (Phase 3)Not Yet RecruitingNCT06548347
What this trial is testing

A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd. 606
Testing effectiveness (Phase 2)UnknownNCT02533700
What this trial is testing

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T Cell LymphomaALK-negative Anaplastic Large Cell Lymphoma+3 more
Shandong Provincial Hospital 106
Post-approval studies (Phase 4)UnknownNCT03631862
What this trial is testing

Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Who this might be right for
Newly Diagnosed Peripheral T-cell Lymphoma
Zhengzhou University 100
Next Page